子宫内膜
间质细胞
免疫组织化学
免疫印迹
生物
孕酮受体
男科
医学
内分泌学
癌症研究
基因
免疫学
雌激素受体
遗传学
生物化学
癌症
乳腺癌
作者
Artjom Stepanjuk,Mariann Koel,Martin Pook,Merli Saare,Kersti Jääger,Maire Peters,Kaarel Krjutškov,Sulev Ingerpuu,Andres Salumets
标识
DOI:10.1016/j.rbmo.2019.05.004
摘要
Abstract Research question How does mucin MUC20 expression change during the menstrual cycle in different cell types of human endometrium? Design Study involved examination of MUC20 expression in two previously published RNA-seq datasets in whole endometrial tissue (n = 10), sorted endometrial epithelial (n = 44) or stromal (n = 42) cell samples. RNA-Seq results were validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR) in whole tissue (n = 10), sorted epithelial (n = 17) and stromal (n = 17) cell samples. MUC20 protein localization and expression were analysed in human endometrium by immunohistochemical analysis of intact endometrial tissue (n = 6) and also Western blot of cultured stromal and epithelial cells (n = 2). Results MUC20 is differentially expressed in the endometrium between the pre-receptive and receptive phases. We show that MUC20 is predominantly expressed by epithelial cells of the receptive endometrium, both at the mRNA (RNA-Seq, P = 0.005; qRT-PCR, P = 0.039) and protein levels (Western blot; immunohistochemistry, P = 0.029). Conclusion Our results indicate MUC20 as a novel marker of mid-secretory endometrial biology. We propose a model of MUC20 function in the hepatocyte growth factor (HGF)-activated mesenchymal–epithelial transition (MET) receptor signalling specifically in the receptive phase. Further investigations should reveal the precise function of MUC20 in human endometrium and the possible connection between MUC20 and HGF-activated MET receptor signalling. MUC20 could potentially be included in the list of endometrial receptivity markers after further clinical validation.
科研通智能强力驱动
Strongly Powered by AbleSci AI